Intrathoracic metastatic spread of parathyroid carcinoma

2010 ◽  
Vol 49 (06) ◽  
pp. N62-N62 ◽  
Author(s):  
C. Maier-Funk ◽  
T. Weber ◽  
G. Lang ◽  
S. Hügl ◽  
S. N. Reske ◽  
...  
2015 ◽  
Vol 100 (3) ◽  
pp. E478-E481 ◽  
Author(s):  
Alexander Shifrin ◽  
Virginia LiVolsi ◽  
Svetlana Shifrin-Douglas ◽  
Min Zheng ◽  
Brian Erler ◽  
...  

Objective: Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other cancers may also occur with up to 10% of cancers from other sites showing parathyroid involvement at autopsy. Tumor-to-tumor metastases (metastatic spread to parathyroid neoplasm) from remote cancers to the parathyroid gland have been described. Methods: We did a PubMed literature review and analysis of our own experience of 392 consecutive parathyroidectomies. Results: Primary and secondary parathyroid malignancies can be grouped into three categories: primary parathyroid carcinoma (PPCa), spread of carcinoma into parathyroid glands by contiguous extension from the thyroid gland or other head and neck cancer, and metastatic disease to the parathyroid gland from distant cancers. Studies of tumor-to-tumor spread indicate a predilection of spread to endocrine tumors possibly because of the rich blood supply that is present in endocrine tumors. Two of our 392 parathyroidectomies (0.5%) had cancer: one metastatic (thymic neuroendocrine tumor) and another PPCa. Conclusion: Metastatic disease to the parathyroid gland is poorly documented. When performing surgery for primary thyroid cancer, the search for parathyroid gland metastases is often overlooked because of the desire to preserve parathyroid function. Metastatic disease from other cancers to a benign parathyroid gland or to a parathyroid adenoma probably suggests a grave prognosis because it likely indicates widespread metastatic disease; however, isolated metastases to the parathyroid may occur. Although these lesions may be uncommon they may not be as rare as once thought.


2015 ◽  
Vol 21 ◽  
pp. 143
Author(s):  
Elizabeth Sanchez Rangel ◽  
Maria Moscoso Cordero ◽  
Vinuta Mohan ◽  
Tasneem Zahra

2017 ◽  
Vol 23 ◽  
pp. 135
Author(s):  
Ahmad Elayyan ◽  
Sindhura Bandaru ◽  
Alexandria McDow ◽  
Joseph White ◽  
Carmel Fratianni ◽  
...  

2017 ◽  
Vol 23 ◽  
pp. 111
Author(s):  
Corin Badiu ◽  
Lidia Radomi ◽  
Daniel Mihai ◽  
Dumitru Ioachim

2014 ◽  
Vol 122 (03) ◽  
Author(s):  
R Jumpertz-von Schwartzenberg ◽  
U Elbelt ◽  
M Ventz ◽  
C Strasburger ◽  
J Spranger

1997 ◽  
Vol 36 (07) ◽  
pp. 256-258 ◽  
Author(s):  
G. F. Fueger ◽  
S. Lax ◽  
Reingard Aigner

SummaryRecent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.


Author(s):  
Joo Yul Choi ◽  
Young Bum Kim ◽  
Guk Haeng Lee ◽  
Myung-Chul Lee

2017 ◽  
Author(s):  
Nagihan Bestepe ◽  
Didem Ozdemir ◽  
Sefika Burcak Polat ◽  
Berna Evranos ◽  
Reyhan Ersoy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document